Tevogen Bio Holdings Inc.
TVGN
$0.9364
$0.0323.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.16M | 21.89M | 23.43M | 17.11M | 15.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.25M | 34.40M | 53.56M | 46.21M | 42.45M |
| Operating Income | -31.25M | -34.40M | -53.56M | -46.21M | -42.45M |
| Income Before Tax | -31.20M | -35.36M | -13.73M | -7.92M | -5.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.20 | -35.36 | -13.73 | -7.92 | -5.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.20M | -35.36M | -13.73M | -7.92M | -5.94M |
| EBIT | -31.25M | -34.40M | -53.56M | -46.21M | -42.45M |
| EBITDA | -31.04M | -34.24M | -53.40M | -46.04M | -42.29M |
| EPS Basic | -0.22 | -0.23 | -0.09 | -0.14 | -0.14 |
| Normalized Basic EPS | -0.14 | -0.16 | -0.25 | -0.25 | -0.25 |
| EPS Diluted | -0.22 | -0.23 | -0.42 | -0.48 | -0.48 |
| Normalized Diluted EPS | -0.14 | -0.16 | -0.25 | -0.25 | -0.24 |
| Average Basic Shares Outstanding | 622.58M | 592.44M | 568.36M | 486.43M | 436.25M |
| Average Diluted Shares Outstanding | 622.58M | 592.44M | 573.42M | 491.48M | 441.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |